Henan Taloph Pharmaceutical Stock Co Ltd600222
± Mixedrelevance
Leadership change with new chairman from audit background; no clear operational or financial impact stated.
Impact on stocks 1
Others
Henan Taloph Pharmaceutical Stock Co LtdTaloph announced that former Chairman Wang Rongtao has resigned due to health reasons and will no longer hold any position at the company. The board has approved the election of Chen Siliang as the new Chairman. The executive is 48 years old and previously served as Deputy Director of the Investment Division at the Zhengzhou Office of the National Audit Office. He currently serves as Deputy Party Secretary, Director, and General Manager of Zhengzhou High-Tech Investment Holding Group, and holds professional qualifications as a cost engineer, senior accountant, and senior auditor.
Henan Taloph Pharmaceutical Stock Co LtdLeadership change with new chairman from audit background; no clear operational or financial impact stated.